Cellceutix to begin clinical trials for anti-cancer drug
10:23 EDT 25 Sep 2012 | Pharmaceutical Business Review
Cellceutix Corporation will commence clinical trials of anti-cancer drug, Kevetrin at Harvard Cancer Center's Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center following the Institutional Review Board (IRB) approval of clinical pr..
Original Article: Cellceutix to begin clinical trials for anti-cancer drug
More From BioPortfolio on "Cellceutix to begin clinical trials for anti-cancer drug"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
